Skip to main content
logo
BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
6.61
-0.20 (-2.94%)
At close: Oct 2, 2026, 4:00 PM EDT
6.74
+0.13 (1.97%)
After-hours: Oct 2, 2026, 7:30 PM EDT

BioAge Labs Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
10.369---
Revenue Growth
168.06%----
Gross Profit
-77.43-64.97-59.04-33.89-
Operating Income
-106.27-92.78-78.19-48.4-39.97
Net Income
-94.46-80.61-71.11-63.85-39.72
Earnings Per Share
-2.37-2.24-6.63-38.17-23.76
EPS Growth
-----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
381.26285.13354.3521.6427.64
Total Debt
2.845.568.753.252.47
Net Cash (Debt)
378.43279.57345.65-31.6125.18
Net Cash Growth
24.21%-19.12%---
Net Cash Per Share
9.507.7832.22-18.9015.06

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-87.6-81.63-51.52-37.36-36.18
Capital Expenditures
-0.49-0.72-0.37-0.17-0.1
Free Cash Flow
-88.09-82.35-51.89-37.53-36.28
Free Cash Flow Growth
-----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Margin
-1026.28%-1031.46%---
Pretax Margin
-912.25%-896.11%---
Profit Margin
-912.25%-896.11%---
FCF Margin
-850.69%-915.46%---

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
29.3052.74---